All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2005-003053-26 | The ZBMUF trial: an open-label randomised study of the effects of ultra-filtration and high dose aprotinin on bivalirudin pharmacokinetics during and/or after cardiopulmonary bypass surgery | 2007-06-22 | due-trials |
| Reported results | 2006-000192-14 | A Clinical Trial Comparing Cangrelor To Clopidogrel In Subjects Who Require Percutaneous Coronary Intervention | 2011-01-17 | due-trials |
| Reported results | 2006-003935-56 | A clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention | 2010-12-12 | due-trials |
| Reported results | 2008-000230-53 | The evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment | 2010-04-25 | due-trials |
| Reported results | 2008-001135-35 | Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trial | 2011-06-06 | due-trials |
| Reported results | 2008-003676-22 | A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure – A Pilot Study (PRONTO) | 2012-04-06 | due-trials |
| Reported results | 2008-007290-20 | Ensayo europeo en ambulancias para tratar el síndrome coronario agudo: EUROMAX | 2014-12-20 | due-trials |
| Reported results | 2010-021424-94 | A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin St... | 2012-11-30 | due-trials |
| Reported results | 2010-021591-28 | A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention | 2012-11-14 | due-trials |
| Reported results | 2010-021720-10 | A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin St... | 2013-06-20 | due-trials |
| Completed, but no date, and reported results Terminated | 2011-004666-15 | A Phase II, double-blind, parallel group, dose-selection study to compare antifibrinolytic MDCO-2010 vs. placebo and tranexamic acid in reducing blood loss in patients undergoing primary cardiac surge... | bad-data | |
| Reported results | 2012-000632-26 | Effect of BivaliRudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3) Effetto di bivalirudina sugli esiti di intervento di sostituzione della valvola aortica 2/3 (BRAVO 2/3) | 2015-06-24 | due-trials |
| Completed, but no date, and reported results | 2012-002314-39 | Bivalirudin Infusion for Ventricular Infarction Limitation | bad-data | |
| Not reported | 2014-000816-32 | A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Fibrocaps™ (Raplixa™) and Tachosil® in Surgical Hemostasis during Hepatic Resection Eine randomis... | 2015-08-12 | due-trials |
| Trial is outside EEC, and reported results | 2014-002405-37 | An open label evaluation of the safety and clinical utility of the active, separated system with enhanced controller (SSEC) fentanyl 40 mcg for the management of acute postoperative pain in pediatric ... | bad-data | |
| Completed, but no date, and reported results Terminated | 2014-005462-30 | A multiple dose, dose-finding, placebo controlled, double blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and evaluate the efficac... | bad-data | |
| Reported results | 2015-000826-13 | A placebo-controlled, double-blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and to evaluate the efficacy, pharmacokinetics, safet... | 2016-10-26 | due-trials |
| Reported results | 2015-003772-74 | A placebo-controlled, double-blind, randomized trial to compare the effect of different doses of ALN-PCSSC given as single or multiple subcutaneous injections in subjects with high cardiovascular risk... | 2017-06-07 | due-trials |
| Completed, but no date Terminated | 2015-004019-19 | A phase II, two-part, multiple-dose, dose-finding, single-blind study to investigate the safety and efficacy of ABP-700 for procedural sedation in adult patients undergoing colonoscopy | bad-data | |
| Reported results | 2016-003376-49 | An Open-Label, Single-Arm, Multicenter Pilot Study to Evaluate Safety, Tolerability, and Efficacy of ALN-PCSSC in Subjects with Homozygous Familial Hypercholesterolemia | 2018-10-08 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2016-003815-37 | An open label, active comparator extension trial to assess the effect of long term dosing of inclisiran and evolocumab given as subcutaneous injections in subjects with high cardiovascular risk and el... | 2021-12-17 | bad-data |
| Reported results | 2017-001846-90 | A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE EFFECT OF 300 MG OF INCLISIRAN SODIUM GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASC... | 2019-07-31 | due-trials |
| Reported results | 2017-002472-30 | A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE EFFECT OF 300 MG OF INCLISIRAN SODIUM GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ... | 2019-08-27 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2017-003092-55 | A long term extension trial of the Phase III lipid-lowering trials to assess the effect of long term dosing of inclisiran given as subcutaneous injections in subjects with high cardiovascular risk and... | 2023-02-13 | bad-data |
| Other | 2017-005066-22 | HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease | not-yet-due |